Pfizer Quietly Adds Language Warning That 'Unfavorable Pre-Clinical, Clinical Or Safety Data' May Impact Business

Discussion about this post

No posts

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

VaxxFacts.info

Pfizer Quietly Adds Language Warning That 'Unfavorable Pre-Clinical, Clinical Or Safety Data' May Impact Business

Pfizer - which just forecast $54 billion in Covid-19 Vaxx related sales in 2022, appears to be anticipating some bad news.

Discussion about this post